Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Vaccine

The First Lyme Disease Vaccine in 24 Years Just Passed Its Pivotal Phase 3 Trial with 74 Percent Efficacy — and It Is for Children Too

Pfizer and Valneva announced Phase 3 VALOR trial results for Lyme disease vaccine PF-07307405 on March 23, 2026: 73.2–74.8% efficacy in ages 5 and older. Regulatory submissions planned for 2026. No Lyme vaccine has been available in the U.S. since 2002.

Medical Daily

Mpox Clade I Has Spread Beyond Africa and Is Now Circulating Locally in Europe. The CDC Expects More U.S. Cases — and the Vaccine Gap Is Getting Harder to Ignore.

More than 20 clade I mpox cases have been confirmed in the U.S. as of June 2026. The CDC now expects additional cases as local clade Ib transmission has been detected in Europe among men who have sex with men with no travel history to Africa. JYNNEOS vaccine uptake lags…

Medical Daily

Whooping Cough Is Still Killing Americans in 2026, and California, Washington, Ohio, and Florida Are Leading a Surge That Is Far from Over

Whooping cough hit its highest U.S. case count in more than a decade in 2024 and 2025, killing infants and adults. In 2026, California leads the nation with nearly 700 cases. Falling vaccination rates, waning immunity, and public health cuts are driving the surge. Here is the full picture.

Medical Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Who is eligible for the MenB vaccine? New one-off programme to protect vulnerable to be rolled out

MenB is a serious bacterial infection caused by Neisseria meningitis group B

The Independent UK

UK to offer free Meningitis B vaccine to 1 million young people after deadly outbreaks

A major NHS programme will offer the meningitis B vaccine to around one million young people across the UK, including Year 13 students and those under 25 starting university. This initiative aims to protect vulnerable individuals entering environments where the disease spreads easily, following recent life-claiming outbreaks.

The Times of India

Meningitis B vaccine: Who is eligible – and when will it be offered?

IN FULL

The Independent UK

UK school leavers and new students to be offered meningitis B vaccine

One-off programme to begin in July after recent MenB outbreaks in Kent, Dorset and Berkshire killed three people

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

One million young people to be offered meningitis B vaccine on NHS after deadly outbreaks

The one-off programme is set to be offered to young people this autumn

The Independent UK

Century-old tuberculosis vaccine could help treat diabetes, trials hint. How?

Repeated doses of a tuberculosis vaccine lowered insulin needs in patients with two forms of diabetes, new trial data show. But more research is needed to prove the benefit.

LiveScience

Two children die from measles as more cases confirmed in London this month

The UKHSA says measles continues to circulate in many parts of the country with 736 cases recorded this year

Evening Standard

OB-GYN group breaks with CDC and issues own vaccine recommendations

The biggest difference involves the COVID-19 vaccine

The Independent UK

Motorcycle taxi drivers in Congo rally for Ebola awareness as attacks hinder response

Dozens of motorcycle taxi drivers have joined an Ebola awareness caravan in eastern Congo

The Independent UK

CDC Admits It Deliberately Delayed COVID-19 Vaccine Study Showing Reduced Hospitalizations

The Centers for Disease Control and Prevention is facing growing scrutiny after officials acknowledged the agency intentionally delayed the release of a study showing the effectiveness of the latest COVID-19 booster, a decision now fueling debate over transparency and public health messaging.

Latin Times

Cattle in England to get tuberculosis vaccine from 2030 as badger cull to end

Targeted vaccination and improved testing planned as part of drive to eradicate disease by 2038

The Guardian - UK

Get all your
news in one place.

100's of premium titles.
One news app.

LiveScience

3 new Ebola vaccines are being fast-tracked amid the current outbreak — when could they be ready?

The Bundibugyo virus driving the current Ebola outbreak has no approved vaccine, but researchers are leveraging decades of vaccine innovation in an effort to change that.

The Independent UK

Bulletin world briefing: Black bear chaos in Japan and major vaccine breakthrough

Here are five of the biggest stories from around the world today

The Independent UK

What is Lassa fever and is there a vaccine for it?

IN FULL

The Independent UK

Lassa fever vaccine for deadly virus within reach after ‘promising’ trial results

About 300,000 Lassa fever infections occur every year killing 5,000 people a year, but a vaccine could save lives

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

World’s first AI-designed vaccine explained

Researchers at the University of Cambridge have developed what they describe as a fundamentally new type of vaccine using artificial intelligence (AI). The vaccine’s key component was designed entirely by AI and has now been tested in people for the first time.

The Independent UK

Oxford University and Moderna to trial pioneering cancer vaccine

IN FULL

The Independent UK

Oxford University and Moderna launch trials of vaccine that could prevent cancer

The jab targets patients with Lynch syndrome, who are at high risk of colorectal and ovarian cancer

The Conversation

The hunt for a new Ebola vaccine: two scientists explain the challenges

The ongoing Ebola virus outbreak in the Democratic Republic of Congo (DRC) and Uganda has now killed 61 people, with 359 confirmed cases. The Bundibugyo strain of the virus has a fatality rate of between 30% and 50%, and there is currently no vaccine approved for it. Two scientists at…

Medical Daily

Breakthrough in Vaccine Science: AI-Designed Universal Coronavirus Shot Shows Safety in First Human Trial

AI-designed universal coronavirus vaccine shows safety and immune response in first human trial, targeting multiple coronaviruses including SARS and MERS.

AAP

FED:Dangerous winter virus far more than 'just a bad cold'

Health authorities are urging seniors to get a free vaccine to protect them from a common winter virus that can cause severe illness, hospitalisation and death.

AAP

Dangerous winter virus far more than 'just a bad cold'

Health authorities are urging seniors to get a free vaccine to protect them from a common winter virus that can cause severe illness, hospitalisation and death.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Centers for Disease Control and Prevention

228 stories

the University of Cambridge

209 stories

the University of Oxford

175 stories

The Conversation Weekly

142 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

the Democratic Republic of Congo

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.